TIM-3 and its regulatory role in immune responses
- PMID: 20700701
- DOI: 10.1007/82_2010_84
TIM-3 and its regulatory role in immune responses
Abstract
T cell immunoglobulin mucin-(TIM)-3 was first identified as a molecule specifically expressed on IFN-γ-secreting CD4(+) T helper 1 (Th1) and CD8(+) T cytotoxic (Tc1) cells in both mice and humans. TIM-3 acts as a negative regulator of Th1/Tc1 cell function by triggering cell death upon interaction with its ligand, galectin-9. This negative regulatory function of TIM-3 has now been expanded to include its involvement in establishing and/or maintaining a state of T cell dysfunction or "exhaustion" observed in chronic viral diseases. In addition, it is now appreciated that TIM-3 has other ligands and is expressed on other cell types, where it may function differently. Given that an increasing body of data support an important role for TIM-3 in both autoimmune and chronic inflammatory diseases in humans, deciphering the function of TIM-3 on different cell types during different immune conditions and how these can be regulated will be critical for harnessing the therapeutic potential of TIM-3 for the treatment of disease.
Similar articles
-
The role of T cell immunoglobulin and mucin domain-3 in immune thrombocytopenia.Scand J Immunol. 2014 Apr;79(4):231-6. doi: 10.1111/sji.12153. Scand J Immunol. 2014. PMID: 24383985 Review.
-
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.Hepatology. 2012 Oct;56(4):1342-51. doi: 10.1002/hep.25777. Hepatology. 2012. PMID: 22505239
-
Tim-2 up-regulation and galectin-9-Tim-3 pathway activation in Th2-biased response in Schistosoma japonicum infection in mice.Immunol Lett. 2012 May 30;144(1-2):60-6. doi: 10.1016/j.imlet.2012.03.007. Epub 2012 Mar 26. Immunol Lett. 2012. PMID: 22469568
-
The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10. Mol Immunol. 2014. PMID: 24333756
-
TIM-3 in autoimmunity.Curr Opin Immunol. 2006 Dec;18(6):665-9. doi: 10.1016/j.coi.2006.09.009. Epub 2006 Oct 2. Curr Opin Immunol. 2006. PMID: 17011764 Review.
Cited by
-
Up-Regulation of Immune Checkpoints in the Thymus of PRRSV-1-Infected Piglets in a Virulence-Dependent Fashion.Front Immunol. 2021 May 11;12:671743. doi: 10.3389/fimmu.2021.671743. eCollection 2021. Front Immunol. 2021. PMID: 34046040 Free PMC article.
-
Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients.Mediators Inflamm. 2018 Nov 22;2018:1632902. doi: 10.1155/2018/1632902. eCollection 2018. Mediators Inflamm. 2018. PMID: 30595665 Free PMC article.
-
Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients.Arthritis Res Ther. 2020 Apr 15;22(1):80. doi: 10.1186/s13075-020-02158-3. Arthritis Res Ther. 2020. PMID: 32293530 Free PMC article.
-
Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients.J Int AIDS Soc. 2015 Oct 19;18(1):20078. doi: 10.7448/IAS.18.1.20078. eCollection 2015. J Int AIDS Soc. 2015. PMID: 26486200 Free PMC article.
-
Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.J Immunol Res. 2016;2016:4683607. doi: 10.1155/2016/4683607. Epub 2016 Jan 4. J Immunol Res. 2016. PMID: 26881264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials